Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection
- 31 July 2009
- journal article
- research article
- Published by Elsevier BV in Clinical Immunology
- Vol. 132 (1), 43-54
- https://doi.org/10.1016/j.clim.2009.03.001
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitroClinical and Experimental Immunology, 2006
- Transfusion of multi-factors activated immune cells as a novel treatment for patients with chronic hepatitis BJournal of Clinical Virology, 2006
- Restoring function in exhausted CD8 T cells during chronic viral infectionNature, 2005
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- How can the cellular immune response control hepatitis B virus replication?Journal of Viral Hepatitis, 2000
- Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis BHepatology, 1997
- Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.The Journal of Experimental Medicine, 1994
- Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donorsClinical and Experimental Immunology, 1994